We observed that GRK5 is significantly higher expressed in mesenchymal-like breast cancer cells and that MDA-MB-231 cells, a metastatic, triple-negative breast cancer cell line, showed the highest GRK5 expression level of all analysed cell lines (Fig. 1A). Here, GRK5 is linked to triple-negative breast carcinoma.